Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Spread across twelve months using CMS's Medicare Prescription Payment Plan (the "smoothing" option), this works out to approximately $167 per month [3]
But the provider was thinking of one concentration and your pharmacy sent a different one
Avoiding excessive alcohol, smoke, and secondhand smoke is a great place to start
Targeted biologic therapies under evaluation for SLE include anifrolumab, belimumab (intravenous and subcutaneous formulations were registered by FDA for use in SLE in 2017) and off-label rituximab, abatacept, tocilizumab, obintuzumab, and eculizumab.[3] The novel biologic therapy, telitacicept, is currently under investigation
US$ 25.92
US$ 21.96
US$ 24.78
